238 related articles for article (PubMed ID: 28440069)
21. Risk of recurrent venous thromboembolism after discontinuation of vitamin K antagonist treatment: a nested case-control study.
Martinez C; Katholing A; Folkerts K; Cohen AT
J Thromb Haemost; 2016 Jul; 14(7):1374-83. PubMed ID: 27079164
[TBL] [Abstract][Full Text] [Related]
22. Mild antithrombin deficiency and risk of recurrent venous thromboembolism: results from the MEGA follow-up study.
Sokol J; Timp JF; le Cessie S; van Hylckama-Vlieg A; Rosendaal FR; Kubisz P; Cannegieter SC; Lijfering WM
J Thromb Haemost; 2018 Apr; 16(4):680-688. PubMed ID: 29377625
[TBL] [Abstract][Full Text] [Related]
23. Risk Scores for Occult Cancer in Patients with Venous Thromboembolism: A Post Hoc Analysis of the Hokusai-VTE Study.
Kraaijpoel N; van Es N; Raskob GE; Büller HR; Carrier M; Zhang G; Lin M; Grosso MA; Di Nisio M
Thromb Haemost; 2018 Jul; 118(7):1270-1278. PubMed ID: 29864787
[TBL] [Abstract][Full Text] [Related]
24. Comparison Between Non-vitamin K Antagonist Oral Anticoagulants and Low-Molecular-Weight Heparin in Asian Individuals With Cancer-Associated Venous Thromboembolism.
Chen DY; Tseng CN; Hsieh MJ; Lan WC; Chuang CK; Pang ST; Chen SW; Chen TH; Chang SH; Hsieh IC; Chu PH; Wen MS; Chen JS; Chang JW; See LC; Huang WK
JAMA Netw Open; 2021 Feb; 4(2):e2036304. PubMed ID: 33533929
[TBL] [Abstract][Full Text] [Related]
25. Cigarette smoking and the risk of venous thromboembolism: the Tromsø Study.
Enga KF; Braekkan SK; Hansen-Krone IJ; le Cessie S; Rosendaal FR; Hansen JB
J Thromb Haemost; 2012 Oct; 10(10):2068-74. PubMed ID: 22882779
[TBL] [Abstract][Full Text] [Related]
26. Impact of time since diagnosis and mortality rate on cancer-associated venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) cohort.
Blix K; Gran OV; Severinsen MT; Cannegieter SC; Jensvoll H; Overvad K; Hammerstrøm J; Tjønneland A; Naess IA; Braekkan SK; Rosendaal FR; Kristensen SR; Hansen JB
J Thromb Haemost; 2018 Jul; 16(7):1327-1335. PubMed ID: 29691978
[TBL] [Abstract][Full Text] [Related]
27. Atrial fibrillation and future risk of venous thromboembolism:the Tromsø study.
Enga KF; Rye-Holmboe I; Hald EM; Løchen ML; Mathiesen EB; Njølstad I; Wilsgaard T; Braekkan SK; Hansen JB
J Thromb Haemost; 2015 Jan; 13(1):10-6. PubMed ID: 25330989
[TBL] [Abstract][Full Text] [Related]
28. Venous thromboembolism and risk of cancer in patients with rheumatoid arthritis.
Pedersen AB; Vandenbroucke J; Horváth-Puhó E; Sørensen HT
J Thromb Haemost; 2017 Dec; 15(12):2325-2332. PubMed ID: 28913891
[TBL] [Abstract][Full Text] [Related]
29. Association between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practice.
Kaatz S; Fu AC; AbuDagga A; LaMori J; Bookhart BK; Damaraju CV; Tan H; Schein J; Nutescu E
Thromb Res; 2014 Oct; 134(4):807-13. PubMed ID: 25127013
[TBL] [Abstract][Full Text] [Related]
30. Effect of prothrombotic genotypes on the risk of venous thromboembolism in patients with and without ischemic stroke. The Tromsø Study.
Rinde LB; Morelli VM; Småbrekke B; Mathiesen EB; Løchen ML; Njølstad I; Wilsgaard T; Smith E; Rosendaal FR; Frazer KA; Braekkan SK; Hansen JB
J Thromb Haemost; 2019 May; 17(5):749-758. PubMed ID: 30773804
[TBL] [Abstract][Full Text] [Related]
31. Prothrombotic fibrin clot properties associated with increased endogenous thrombin potential and soluble P-selectin predict occult cancer after unprovoked venous thromboembolism.
Mrozinska S; Cieslik J; Broniatowska E; Malinowski KP; Undas A
J Thromb Haemost; 2019 Nov; 17(11):1912-1922. PubMed ID: 31323706
[TBL] [Abstract][Full Text] [Related]
32. Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosis.
Schulman S; Zondag M; Linkins L; Pasca S; Cheung YW; de Sancho M; Gallus A; Lecumberri R; Molnar S; Ageno W; Le Gal G; Falanga A; Hulegårdh E; Ranta S; Kamphuisen P; Debourdeau P; Rigamonti V; Ortel TL; Lee A
J Thromb Haemost; 2015 Jun; 13(6):1010-8. PubMed ID: 25851122
[TBL] [Abstract][Full Text] [Related]
33. Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study.
Chee CE; Ashrani AA; Marks RS; Petterson TM; Bailey KR; Melton LJ; Heit JA
Blood; 2014 Jun; 123(25):3972-8. PubMed ID: 24782507
[TBL] [Abstract][Full Text] [Related]
34. The occurrence of venous thromboembolism in cancer patients following major surgery.
Toledano TH; Kondal D; Kahn SR; Tagalakis V
Thromb Res; 2013 Jan; 131(1):e1-5. PubMed ID: 23174626
[TBL] [Abstract][Full Text] [Related]
35. Repeated measurements of carotid atherosclerosis and future risk of venous thromboembolism: the Tromsø Study.
Småbrekke B; Rinde LB; Hald EM; Njølstad I; Mathiesen EB; Johnsen SH; Hansen JB; Braekkan SK; Lijfering WM
J Thromb Haemost; 2017 Dec; 15(12):2344-2351. PubMed ID: 28981216
[TBL] [Abstract][Full Text] [Related]
36. Role of family history of venous thromboembolism and thrombophilia as predictors of recurrence: a prospective follow-up study.
Sundquist K; Sundquist J; Svensson PJ; Zöller B; Memon AA
J Thromb Haemost; 2015 Dec; 13(12):2180-6. PubMed ID: 26407905
[TBL] [Abstract][Full Text] [Related]
37. Incremental health care resource utilization and economic burden of venous thromboembolism recurrence from a U.S. payer perspective.
Lin J; Lingohr-Smith M; Kwong WJ
J Manag Care Pharm; 2014 Feb; 20(2):174-86. PubMed ID: 24456319
[TBL] [Abstract][Full Text] [Related]
38. High rate of recurrent venous thromboembolism in children and adolescents with unprovoked venous thromboembolism.
Whitworth H; Clark HH; Hubbard RA; Witmer C; Leonard CE; Raffini L
J Thromb Haemost; 2023 Jan; 21(1):47-56. PubMed ID: 36695395
[TBL] [Abstract][Full Text] [Related]
39. The impact of initial cancer stage on the incidence of venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) Cohort.
Gade IL; Braekkan SK; Naess IA; Hansen JB; Cannegieter SC; Overvad K; Jensvoll H; Hammerstrøm J; Blix K; Tjønneland A; Kristensen SR; Severinsen MT
J Thromb Haemost; 2017 Aug; 15(8):1567-1575. PubMed ID: 28585779
[TBL] [Abstract][Full Text] [Related]
40. Venous thromboembolism increases the risk of atrial fibrillation: the Tromso study.
Hald EM; Enga KF; Løchen ML; Mathiesen EB; Njølstad I; Wilsgaard T; Braekkan SK; Hansen JB
J Am Heart Assoc; 2014 Jan; 3(1):e000483. PubMed ID: 24385452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
